Actuate Therapeutics CEO buys 140,844 shares
The public-offering purchase included one detachable warrant for every two common shares acquired.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Actuate Therapeutics, Inc. (ACTU) President, CEO and Director Daniel M. Schmitt reported purchasing 140,844 common shares at $0.355 per share on October 28, 2026, in connection with the issuer’s public offering. He also acquired 70,422 detachable warrants. His direct common-stock holdings following the transaction were 442,560 shares. Separately, The Schmitt Family Irrevocable Trust held 564,071 shares; The Andrew Schmitt, The Anna Schmitt and The Edward Schmitt Irrevocable Trusts each held 22,223 shares. No Rule 10b5-1 plan is reported.
Insights
Analyzing...
Insider Trade Summary
Net Buyer: 211,266 shares
Net Buy
6 txns
Insider
SCHMITT DANIEL M
Role
President, CEO and Director
Bought
211,266 shs ($50K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Purchase | Warrant to Purchase Common Stock F2 | 70,422 | $0.00 | $0.00 |
| Purchase | Common Stock F1 | 140,844 | $0.355 | $50K |
| holding | Common Stock F3 | -- | -- | -- |
| holding | Common Stock F4 | -- | -- | -- |
| holding | Common Stock F5 | -- | -- | -- |
| holding | Common Stock F6 | -- | -- | -- |
Holdings After Transaction:
Warrant to Purchase Common Stock — 70,422 contracts (Direct);
Common Stock — 442,560 shares (Direct);
Common Stock — 564,071 shares (Indirect, By The Schmitt Family Irrevocable Trust, dated December 31, 2019);
Common Stock — 22,223 shares (Indirect, By The Andrew Schmitt Irrevocable Trust, dated December 31, 2019);
Common Stock — 22,223 shares (Indirect, By The Anna Schmitt Irrevocable Trust, dated December 31, 2019);
Common Stock — 22,223 shares (Indirect, By The Edward Schmitt Irrevocable Trust, dated December 31, 2019)
Footnotes (6)
- F1. Represents shares of common stock purchased on October 28, 2026 in connection with Issuers public offering.
- F2. Represents detachable warrants acquired on October 28, 2026 in connection with Issuers public offering. For every two shares of common stock acquired in connection with the public offering, one detachable warrant was issued for no additional consideration. The warrant is immediately exercisable and expires 5 years from this issuance date.
- F3. Represents shares held by The Schmitt Family Irrevocable Trust, dated December 31, 2019, of which the reporting person is trustee (the "Schmitt Family Trust").
- F4. Represents shares held by The Andrew Schmitt Irrevocable Trust, dated December 31, 2019, of which the reporting person is trustee.
- F5. Represents shares held by The Anna Schmitt Irrevocable Trust, dated December 31, 2019, of which the reporting person is trustee.
- F6. Represents shares held by The Edward Schmitt Irrevocable Trust, dated December 31, 2019, of which the reporting person is trustee.
Key Figures
Common shares purchased: 140,844 shares
Purchase price: $0.355 per share
Detachable warrants acquired: 70,422 warrants
+4 more
7 metrics
Common shares purchased
140,844 shares
October 28, 2026
Purchase price
$0.355 per share
Common shares purchased in connection with the public offering
Detachable warrants acquired
70,422 warrants
October 28, 2026
Warrant exercise price
$0.45 per share
Warrants expire October 28, 2031
Direct common shares following transaction
442,560 shares
Daniel M. Schmitt’s reported direct holdings
Schmitt Family Irrevocable Trust shares
564,071 shares
Shares held by the trust
Shares in each of three Schmitt Irrevocable Trusts
22,223 shares
Each of the Andrew, Anna and Edward Schmitt Irrevocable Trusts
Key Terms
detachable warrants, immediately exercisable, public offering, Irrevocable Trust
4 terms
detachable warrants financial
"one detachable warrant was issued"
Detachable warrants are stand-alone rights that can be separated from another security (like a bond or preferred share) and traded on their own; each warrant gives the holder the option to buy the issuer’s stock at a set price before a deadline. They matter to investors because they offer a low-cost, time-limited way to gain potential upside like a lottery ticket while remaining tradable independently—which affects a company’s future share count and can change investment value and dilution expectations.
immediately exercisable financial
"The warrant is immediately exercisable"
public offering financial
"in connection with Issuers public offering"
A public offering is when a company sells shares to the general public through the stock market, either by issuing new shares to raise cash or by letting existing owners sell their stakes. Think of it like a business opening its doors to many new owners at once: it can bring in money for growth but also increases the number of shares available, which can change the stock price and dilute existing ownership — key factors investors watch closely.
Irrevocable Trust financial
"The Schmitt Family Irrevocable Trust"
An irrevocable trust is a legal arrangement where an owner transfers assets into a separate entity managed by a trustee and gives up the power to modify or reclaim those assets. For investors it matters because putting stock or other holdings into such a trust can change who controls and benefits from the assets, affect taxes and creditor protection, and influence how easy it is to sell or value those holdings—like placing valuables in a locked safe overseen by someone else.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What warrant terms did Daniel M. Schmitt report for ACTU?
He acquired 70,422 detachable warrants for no additional consideration; one warrant was issued for every two common shares acquired. The warrants are immediately exercisable at $0.45 per share and expire October 28, 2031.
AI-generated analysis. How Rhea-AI works. Not financial advice.
